Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare armodafinil, bupropion, curcumin, and
minocycline when given alone or in combination to learn which is better for controlling
symptoms, such as the side effects of chemoradiation, when given to treat lung cancer.